ABCC3 Polymorphisms and mRNA Expression Influence the

Luchessi, Andre Ducati; Concheiro, Marta; Germano, Juliana de Freitas; Silbiger, Vivian Nogueira; Bortolin, Raul Hernandes; Cruz, Angelines; Quintela, Oscar; Brion, Maria; Carracedo, Angel; Iniguez, Andres; Bravo, Marisol; Lopez-Rivadulla, Manuel; Hirata, Rosario Dominguez Crespo; Sousa, Amanda Guerra Moraes Rego; Hirata, Mario Hiroyuki.
Basic Clin Pharmacol Toxicol ; 120(5): 466-474, 2017. graf, tab
Artículo en Inglés | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1060444

Documentos relacionados

  1. Validation of a computerized decision support system to review pharmacotherapy treatment: scheduling guidelines.
  2. The biochemistry of disease: desperately seeking syzygy.
  3. RNA-based therapeutics: ready for delivery?
  4. Aortite chez une patiente recevant une chimiothérapie.
  5. Evaluating automated entity extraction with respect to drug and non-drug treatment strategies.
  6. Communication in Drug Development: "Translating" Scientific Discovery.
  7. Prediction of drug's Anatomical Therapeutic Chemical (ATC) code by integrating drug-domain network.
  8. [Dissonance in addictology - The missed encounter between Laszlo Levendel and Thomas Szasz].
  9. [Health-Related Quality of Life in the Context of Early Benefit Assessment of Drugs According to § 35a of the German Social Code Book V: A Challenging Endpoint for all the Involved Stakeholders].
  10. Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis.